345 related articles for article (PubMed ID: 26972381)
21. Poly(lactic-
Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
[TBL] [Abstract][Full Text] [Related]
22. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
[TBL] [Abstract][Full Text] [Related]
23. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
24. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release.
Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J
Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599
[TBL] [Abstract][Full Text] [Related]
25. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
26. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
[TBL] [Abstract][Full Text] [Related]
27. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of Antifungal Activity of Juglone (5-Hydroxy-1,4-naphthoquinone) Using a Poly(d,l-lactic-co-glycolic acid) (PLGA) Nanoparticle System.
Arasoglu T; Mansuroglu B; Derman S; Gumus B; Kocyigit B; Acar T; Kocacaliskan I
J Agric Food Chem; 2016 Sep; 64(38):7087-94. PubMed ID: 27600097
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
30. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticle delivery systems formed using electrically sprayed co-flowing excipients and active agent.
Bakhshi R; Ahmad Z; Soric M; Stride E; Edirisinghe M
J Biomed Nanotechnol; 2011 Dec; 7(6):782-93. PubMed ID: 22416577
[TBL] [Abstract][Full Text] [Related]
32. Effect of lyophilization on liposomal encapsulation of salmon calcitonin.
Swaminathan J; Ehrhardt C
J Liposome Res; 2014 Dec; 24(4):297-303. PubMed ID: 24708057
[TBL] [Abstract][Full Text] [Related]
33. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide).
Jeong YI; Shim YH; Kim C; Lim GT; Choi KC; Yoon C
J Microencapsul; 2005 Sep; 22(6):593-601. PubMed ID: 16401576
[TBL] [Abstract][Full Text] [Related]
34. Development and optimization of N-Acetylcysteine-loaded poly (lactic-co-glycolic acid) nanoparticles by electrospray.
Karimi Zarchi AA; Abbasi S; Faramarzi MA; Gilani K; Ghazi-Khansari M; Amani A
Int J Biol Macromol; 2015 Jan; 72():764-70. PubMed ID: 25224287
[TBL] [Abstract][Full Text] [Related]
35. Development and Optimization of Dual Drugs (Isoniazid and Moxiflox-acin) Loaded Functional PLGA Nanoparticles for the Synergistic Treatment of Tuberculosis.
Moin A; Raizaday A; Hussain T; Nagshubha B
Curr Drug Deliv; 2016; 13(7):1034-1052. PubMed ID: 27138300
[TBL] [Abstract][Full Text] [Related]
36. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
Yadav KS; Sawant KK
Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
[TBL] [Abstract][Full Text] [Related]
37. Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage.
Holzer M; Vogel V; Mäntele W; Schwartz D; Haase W; Langer K
Eur J Pharm Biopharm; 2009 Jun; 72(2):428-37. PubMed ID: 19462479
[TBL] [Abstract][Full Text] [Related]
38. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
39. Engineering Atrazine Loaded Poly (lactic- co-glycolic Acid) Nanoparticles to Ameliorate Environmental Challenges.
Schnoor B; Elhendawy A; Joseph S; Putman M; Chacón-Cerdas R; Flores-Mora D; Bravo-Moraga F; Gonzalez-Nilo F; Salvador-Morales C
J Agric Food Chem; 2018 Aug; 66(30):7889-7898. PubMed ID: 30039704
[TBL] [Abstract][Full Text] [Related]
40. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
Abrego G; Alvarado HL; Egea MA; Gonzalez-Mira E; Calpena AC; Garcia ML
J Pharm Sci; 2014 Oct; 103(10):3153-64. PubMed ID: 25091511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]